MLTX COURT NEWS: MoonLake Immunotherapeutics Investor Deadline December 15 – Investors Notified to Contact BFA Law to Potentially Recover Losses
NEW YORK CITY, NY / ACCESS Newswire / November 4, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ:MLTX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged […]